Evidence mapPaperPMID 41395693Full record

Trial reportDiabetes, obesity & metabolism2026

Taxonomic and functional shifts in the microbiome of severely obese, prediabetic patients: Ketogenic diet versus energy-matched standard diet.

June Stone, Afroditi Tripyla, Melanie C Scalise, Maria L Balmer, Lia Bally, Dominik M Meinel

Abstract readRandomized Controlled TrialComparative Study
In one paragraph

Trial report in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

June StoneInstitut für Bioanalytik, Hochschule für Lifesciences, Fachhochschule Nordwestschweiz, Muttenz, Switzerland.
Afroditi TripylaDepartment of Diabetes, Endocrinology, Nutritional Medicine and Metabolism Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.ORCID 0000-0002-6096-0009
Melanie C ScaliseDiabetes Center Berne, Bern, Switzerland.ORCID 0009-0009-8213-0725
Maria L BalmerDiabetes Center Berne, Bern, Switzerland.ORCID 0000-0003-0356-6352
Lia BallyDepartment of Diabetes, Endocrinology, Nutritional Medicine and Metabolism Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.ORCID 0000-0003-1993-7672
Dominik M MeinelInstitut für Bioanalytik, Hochschule für Lifesciences, Fachhochschule Nordwestschweiz, Muttenz, Switzerland.ORCID 0000-0003-2328-9794

Funding

Nestlé Health SciencePierre Mercier FoundationSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung PCEFP3_194618/1Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung PCEGP3_186978Stiftung FHNW
6 · The paper itself

Abstract

aimsObesity and type 2 diabetes mellitus (T2DM) are among the leading global health challenges of the 21st century. While caloric restriction remains the cornerstone of weight loss interventions, ketogenic diets (KD), characterised by low carbohydrate and high fat intake, have been shown to improve metabolic health partly by modulating the gut microbiome. This study investigated the effects of a short-term KD on gut microbiome composition and function in severely obese, prediabetic patients, compared to an energy-matched standard diet (SD).

methodsIn a randomised trial, patients with BMI >35 kg/m

resultsAt baseline, prediabetic patients exhibited greater interindividual variability and lower alpha diversity than healthy controls. KD resulted in a significant reduction of alpha diversity, largely driven by a selective loss of Lachnospiraceae, with a concomitant increase in Bacteroidaceae. Functional profiling revealed that KD, but not SD, altered genes coding for enzymes involved in energy metabolism, amino acid synthesis, nucleic acid activity, RNA modification, and vitamin biosynthesis. Additionally, serum acetate levels increased significantly following KD.

conclusionsThese findings underscore that KD, independent of caloric intake, acutely remodels the gut microbiome's taxonomic and functional landscape, highlighting the microbiome as a potential mediator of KD's metabolic effects.

Indexed as

Diet, KetogenicGastrointestinal MicrobiomeObesityObesity, MorbidPrediabetic StateAdultCaloric RestrictionDiabetes Mellitus, Type 2FecesFemaleHumansMaleMiddle Agedclinical trialdietary interventionenergy regulationobesity therapy

Identifiers

PMID41395693
PMCPMC12890762

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.